Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Numbers of Patients in each group.

More »

Table 1 Expand

Figure 1.

Distribution of deliveries in TPEHG dataset.

More »

Figure 1 Expand

Figure 2.

PCA for features extracted from the Channel 3 0.34–1 Hz filtered signal.

More »

Figure 2 Expand

Figure 3.

Distribution of deliveries in TPEHG dataset after the SMOTE technique is applied.

More »

Figure 3 Expand

Table 2.

Summary of Classifiers, Features, Validation Techniques and Sample Sizes used in this study.

More »

Table 2 Expand

Table 3.

Classifier Performance Results for the 0.34–1 Hz Filter.

More »

Table 3 Expand

Table 4.

Cross Validation Results for the 0.34–1 Hz Filter.

More »

Table 4 Expand

Figure 4.

Received Operator Curve for the 0.34–1 Hz Filter.

More »

Figure 4 Expand

Table 5.

Classifier Performance Table for Oversampled 0.34–1 Hz Signal.

More »

Table 5 Expand

Table 6.

Cross Validation Results for Oversampled 0.34–1 Hz Signal.

More »

Table 6 Expand

Figure 5.

Received Operator Curve for Oversampled 0.34–1 Hz Signal.

More »

Figure 5 Expand

Table 7.

Classifier Performance for Oversampled 0.34–1 Hz Signal with additional Features.

More »

Table 7 Expand

Table 8.

Cross Validation Results for Oversampled 0.34–1 Hz Signal with additional Features.

More »

Table 8 Expand

Figure 6.

Received Operator Curve for Oversampled 0.34–1 Hz Signal with additional features.

More »

Figure 6 Expand

Table 9.

Classifier Performance for Clinical Data Only.

More »

Table 9 Expand

Table 10.

Cross Validation Results for Clinical Data Only.

More »

Table 10 Expand

Figure 7.

Received Operator Curve for Clinical Data Only.

More »

Figure 7 Expand

Table 11.

Summary of Classifier Performance for Original TPEHG Dataset and Oversampled Dataset Using SMOTE.

More »

Table 11 Expand

Table 12.

Summary of Classifier Performance for Oversampling with Additional Features and Clinical Data Only.

More »

Table 12 Expand